Search Results

You searched for : Abcellera

	AbCellera-Discovered Antibody, Bebtelovimab, receives FDA Emergency Use Authorization for the treatment COVID-19 Treatment of mild and moderate Covid19 ... Feb 14
	AbCellera announces collaboration with Moderna to discover Therapeutic Antibodies for mRNA medicines Latest pharma news updates... Sep 20
	AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19 Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
	Lilly initiates phase 3 trial of LY-CoV555 for prevention of COVID-19 More than 40 percent of coronavirus deaths in the U.S. linked to long-term care facilities;... Aug 03
	Lilly's COVID-19 drug could be ready by September Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the coronavirus that could enter human clinical trials in ... Jun 11
	ELI Lilly Begins Worldâ€™s First Study of a Potential COVID-19 Antibody Treatment This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera ... Jun 06
	AbCellera and Eli Lilly Agreed to Co-develop Antibody Products to Fight COVID-19 AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create ... Mar 13
7 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

AbCellera-Discovered Antibody, Bebtelovimab, receives FDA Emergency Use Authorization for the treatment COVID-19

AbCellera announces collaboration with Moderna to discover Therapeutic Antibodies for mRNA medicines

AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19

Lilly initiates phase 3 trial of LY-CoV555 for prevention of COVID-19

Lilly's COVID-19 drug could be ready by September

ELI Lilly Begins Worldâ€™s First Study of a Potential COVID-19 Antibody Treatment

AbCellera and Eli Lilly Agreed to Co-develop Antibody Products to Fight COVID-19

Trending Now